Mucolipidosis type IV

Metabolic diseases
Pediatric diseases

General description

Mucolipidosis type IV (MLIV) represents a rare autosomal recessive lysosomal storage disorder that profoundly affects neurodevelopment and visual function through mutation of the MCOLN1 gene coding the TRPML1 channel protein.

Clinical manifestations

The clinical presentation of MLIV typically manifests within the first year of life with severe global developmental delay affecting motor, cognitive, and visual domains. Most patients demonstrate profound psychomotor retardation characterized by delayed achievement of developmental milestones.

Visual impairment represents a prominent and progressive feature of MLIV, encompassing multiple ocular abnormalities including bilateral corneal clouding, retinal degeneration, and optic atrophy.

Gastrointestinal manifestations include constitutive achlorhydria resulting from absence of gastric acid secretion, which leads to secondary elevation of blood gastrin levels and frequently causes iron deficiency anemia.

References

  1. Frei, K. P., et al. "Mucolipidosis type IV: characteristic MRI findings." Neurology 51.2 (1998): 565-569.

White matter lesion

Anatomical regions
  • Cerebrum
    Cerebral white matter
    Deep white matter
Symmetric
Bilateral
T2WI
Hyperintensity
FLAIR
Hyperintensity

MRI demonstrates diffuse hyperintensity on T2-weighted images, sparing subcortical white matter.

Corpus callosum abnormality

Anatomical regions
  • Corpus callosum
Morphology
Atrophy
Thinning
Aplasty

The corpus callosum demonstrates consistent and characteristic abnormalities in MLIV patients, with hypoplasia representing the most prominent finding across virtually all affected individuals.

Iron deposition

Anatomical regions
  • Thalamus
  • Caudate nucleus
  • Putamen
  • Globus pallidus
Symmetric
Bilateral
T1WI
Hyperintensity
T2WI
Hypointensity
FLAIR
Hypointensity

Brain iron accumulation represents another pathognomonic feature of MLIV, with increased ferritin deposition consistently observed in the thalamus and basal ganglia.